CompletedNot Applicable

FemPulse Therapy for Overactive Bladder in Women

United States21 participantsStarted 2018-12-11

Plain-language summary

The purpose of this clinical trial is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.

Who can participate

Age range21 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Females 21 years or older with a diagnosis of Overactive Bladder * If of reproductive age, must use a reliable form of contraception Exclusion Criteria: * Pregnant, was recently pregnant or is trying to conceive * Has a metal pelvic implant or any electrically active implanted medical device * Had a previous hysterectomy, pelvic radiation or pelvic cancer * Has significant pelvic organ prolapse * Had bladder treatment with onabotulinumtoxinA in the previous 12 months * Has a significant heart condition